| Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody DR Burton, J Pyati, R Koduri, SJ Sharp, GB Thornton, PWHI Parren, ... Science 266 (5187), 1024-1027, 1994 | 1428 | 1994 |
| The Drosophila homology of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless F Rijsewijk, M Schuermann, E Wagenaar, P Parren, D Weigel, R Nusse Cell 50 (4), 649-657, 1987 | 1424 | 1987 |
| Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors M De Weers, YT Tai, MS Van Der Veer, JM Bakker, T Vink, DCH Jacobs, ... The Journal of Immunology 186 (3), 1840-1848, 2011 | 1218 | 2011 |
| Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design EO Saphire, PWHI Parren, R Pantophlet, MB Zwick, GM Morris, PM Rudd, ... science 293 (5532), 1155-1159, 2001 | 1153 | 2001 |
| Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange M Van Der Neut Kolfschoten, J Schuurman, M Losen, WK Bleeker, ... Science 317 (5844), 1554-1557, 2007 | 1145 | 2007 |
| Bispecific antibodies: a mechanistic review of the pipeline AF Labrijn, ML Janmaat, JM Reichert, PWHI Parren Nature reviews Drug discovery 18 (8), 585-608, 2019 | 1119 | 2019 |
| Fc receptor but not complement binding is important in antibody protection against HIV AJ Hessell, L Hangartner, M Hunter, CEG Havenith, FJ Beurskens, ... Nature 449 (7158), 101-104, 2007 | 1065 | 2007 |
| Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41 MB Zwick, AF Labrijn, M Wang, C Spenlehauer, EO Saphire, JM Binley, ... Journal of virology 75 (22), 10892-10905, 2001 | 1039 | 2001 |
| Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas JL Teeling, RR French, MS Cragg, J van den Brakel, M Pluyter, H Huang, ... Blood 104 (6), 1793-1800, 2004 | 882 | 2004 |
| The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20 JL Teeling, WJM Mackus, LJJM Wiegman, JHN van den Brakel, SA Beers, ... The Journal of Immunology 177 (1), 362-371, 2006 | 846 | 2006 |
| Complement is activated by IgG hexamers assembled at the cell surface CA Diebolder, FJ Beurskens, RN De Jong, RI Koning, K Strumane, ... Science 343 (6176), 1260-1263, 2014 | 842 | 2014 |
| Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro PWHI Parren, PA Marx, AJ Hessell, A Luckay, J Harouse, C Cheng-Mayer, ... Journal of virology 75 (17), 8340-8347, 2001 | 836 | 2001 |
| Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques AJ Hessell, P Poignard, M Hunter, L Hangartner, DM Tehrani, WK Bleeker, ... Nature medicine 15 (8), 951-954, 2009 | 692 | 2009 |
| Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma MB Overdijk, S Verploegen, M Bögels, M van Egmond, JJL van Bueren, ... MAbs 7 (2), 311-320, 2015 | 546 | 2015 |
| On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. PW Parren, PA Warmerdam, LC Boeije, J Arts, NA Westerdaal, A Vlug, ... The Journal of clinical investigation 90 (4), 1537-1546, 1992 | 498 | 1992 |
| Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1 M Hezareh, AJ Hessell, RC Jensen, JGJ van de Winkel, PWHI Parren Journal of virology 75 (24), 12161-12168, 2001 | 496 | 2001 |
| Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange AF Labrijn, JI Meesters, BECG de Goeij, ETJ van den Bremer, J Neijssen, ... Proceedings of the National Academy of Sciences 110 (13), 5145-5150, 2013 | 438 | 2013 |
| In vitro characterization of five humanized OKT3 effector function variant antibodies D Xu, ML Alegre, SS Varga, AL Rothermel, AM Collins, VL Pulito, ... Cellular immunology 200 (1), 16-26, 2000 | 425 | 2000 |
| The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. PWHI Parren, JP Moore, DR Burton, QJ Sattentau | 417 | 1999 |
| Targeting interleukin‐15 in patients with rheumatoid arthritis: a proof‐of‐concept study B Baslund, N Tvede, B Danneskiold‐Samsoe, P Larsson, G Panayi, ... Arthritis & Rheumatism 52 (9), 2686-2692, 2005 | 403 | 2005 |
Rob N. de JongGenmabبريد إلكتروني تم التحقق منه على genmab.com